Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)
Phase 4
Completed
- Conditions
- Chronic Low Back Pain
- Registration Number
- NCT00090181
- Lead Sponsor
- Organon and Co
- Brief Summary
The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 401
Inclusion Criteria
- Male and female patients 18 years of age or older, who have Chronic Low Back Pain after the discontinuation of their previous medication for their condition.
- Patients should have at least 3 months of Low Back Pain.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Safety and tolerability Lower back pain intensity
- Secondary Outcome Measures
Name Time Method Patient global assessment of response to therapy Disability questionnaire